Aflibercept 8 mg first to achieve sustained vision gains with more than 70% of patients extended to intervals between 16 and 24 weeks in wet age-related macular degeneration at two years

Berlin, August 10, 2023 – Bayer today announced two-year (96 weeks) topline results of the pivotal clinical trial PULSAR in patients with neovascular (wet) age-related macular degeneration (nAMD). The data reinforce sustained vision gains with unprecedented extended treatment intervals of aflibercept 8 mg reaching up to 24 weeks with efficacy and safety comparable to the

Read more

8BitDo’s first keyboard includes huge NES buttons

It seems like everyone and their mother subsidiary companies are jumping on the red-hot mechanical keyboard trend. The latest entrant is 8BitDo, best known for its retro-style (and surprisingly advanced) game controllers. The manufacturer is staying in its comfort zone with its first keyboard design: The Retro Mechanical Keyboard is offered in two colorways…

Read more

This website is using cookies to improve the user-friendliness. You agree by using the website further.

Privacy policy
Skip to content